Mercia Asset Management Dividends - MERC

Mercia Asset Management Dividends - MERC

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Mercia Asset Management Plc MERC London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 39.00 08:00:00
Open Price Low Price High Price Close Price Previous Close
39.00 39.00 39.00 39.00
more quote information »
Industry Sector
GENERAL FINANCIAL

Mercia Asset Management MERC Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
06/07/2021FinalGBX0.331/03/202031/03/202123/09/202124/09/202112/10/20210.4
01/12/2020InterimGBX0.130/03/202030/09/202010/12/202011/12/202030/12/20200

Top Dividend Posts

DateSubject
03/9/2021
10:38
turbocharge: Friday 3 September 2021 Mercia invests GBP1.6million as part of a GBP10.0million syndicated round into Locate Bio Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.GBP940million of assets under management, is pleased to announce a significant syndicated investment into existing direct investment portfolio company Locate Bio Limited ("Locate Bio"), a Nottingham-based business developing a range of orthobiologics.
10/7/2021
10:52
p1nkfish: Not a fan of Stockopaedia either. Good for sheep. ST probably has embargoed Merc. He had a valid point but the ability to change opinion on prospect of changing outcome differentiates. The average 3 Yr plan average return is to help smooth out lumpiness.
09/7/2021
12:14
varies: undervaluedassets I too am a believer in MERC but I do not regard the earnings achieved in 2020 as a reliable base for future years and feel that the PER of 4.9 is not in these circumstances a useful tool for assessing the company's worth. I believe that the NAV is more relevant and that the directors' figure of 40p is very conservative indeed. These earnings included gains made on disposals that may well recur in 2021 and 2022 but are not to my mind of an income nature. The dividends declared are very welcome but the amount (0.4p p.a.) suggests to me that the underlying recurrent profits of MERC are nearer 1p than 5p.
23/4/2021
10:08
tomps2: MERC virtual investor event, held on the 20/04/21 This showcases Mercia’s team, portfolio companies and an overview of the Group’s recent performance. Led by Mercia’s CEO Dr Mark Payton, this provides insight on the progress that Mercia is making on its three-year strategy. Mark was joined by Martin Glanfield, CFO, Julian Viggars, CIO and Jill Williams, Investment Director. The event includes short presentations from the CEOs of several Mercia investee companies within both its direct investment portfolio and third-party manage funds’ portfolios. At the end there is a short Q&A. Watch the event here: Https://www.piworld.co.uk/2021/04/23/mercia-asset-management-merc-virtual-shareholder-event-april-2021/ Or listen to the podcast version here: Https://piworld.podbean.com/e/mercia-asset-management-merc-virtual-shareholder-event-april-2021/
21/4/2021
13:30
bb123: Notice of Results year ended 31 March 2021 on Tuesday 6 July 2021. Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£872million of assets under management, will announce its preliminary results for the year ended 31 March 2021 on Tuesday 6 July 2021. An analyst webcast will be given by Dr Mark Payton, Chief Executive Officer, Martin Glanfield, Chief Financial Officer, and Julian Viggars, Chief Investment Officer, at 9.30am on the day of results. Analysts wishing to register are asked to contact mercia@fticonsulting.com. In addition, as part of its continuing commitment to appropriate and open communication with all shareholders, Mercia is pleased to announce that it will also provide a live presentation and Q&A via the Investor Meet Company platform at 3.00pm on the same day. Registration details will be provided nearer the announcement date. Ends For further information, please contact: Mercia Asset Management PLC Mark Payton, Chief Executive Officer Martin Glanfield, Chief Financial Officer www.mercia.co.uk +44 (0)330 223 1430 Canaccord Genuity Limited (NOMAD and Joint Broker) +44 (0)20 7523 8000 Simon Bridges, Emma Gabriel, Richard Andrews N+1 Singer (Joint Broker) Harry Gooden, James Moat +44 (0)20 7496 3000 FTI Consulting +44 (0)20 3727 1051 Tom Blackwell, Louisa Feltes, Shiv Talwar mercia@fticonsulting.com About Mercia Asset Management PLC Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet. The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£872million of assets under management and, since its IPO in December 2014, has invested c.£106million gross into its direct investment portfolio. Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC". This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
12/4/2021
09:34
tomps2: Mercia Asset Management PLC #MERC are hosting a virtual investor event, The Mercia Brief which will showcase Mercia's team, portfolio companies and provide an overview of the Group's recent performance. The presentations will be followed by a Q&A. Mark Payton - Mercia Asset Management, CEO will provide insight on the progress that Mercia is making on its three-year strategy. Mark will be joined by Martin Glanfield, CFO, Julian Viggars, CIO and Jill Williams, Investment Director and Mercia's ESG Lead. The event will also include short presentations from the CEOs of several Mercia investee companies within both its direct investment portfolio and third-party managed funds' portfolios. Tuesday 20th April, 4-5 pm. Register here: [...] We look forward to seeing you.
06/4/2021
16:18
cheshire man: Tue, 6th Apr 2021 14:37 RNS Number : 5487U Mercia Asset Management PLC 06 April 2021 RNS 6 April 2021 Mercia Asset Management PLC ("Mercia" the "Company" or the "Group") MyHealthChecked plc signs major contract Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£872million of assets under management, notes today's announcement by its AIM quoted direct investment portfolio company MyHealthChecked plc (AIM: MHC), that is has signed a significant commercial contract with Boots UK Limited, the health and beauty retailer and pharmacy group. MyHealthChecked plc is a fast growing personalised healthcare company. It became a direct investment in 2016, and, as at 30 September 2020, Mercia's 14.6% beneficial stake was valued at £675,000 based upon the closing bid price of 0.8 pence per share. Mercia currently holds 101,992,932 shares in MyHealthChecked plc, representing a direct beneficial stake of 14.1%. Mark Payton, Chief Executive Officer of Mercia, said: "We are pleased to note this significant commercial milestone for MyHealthChecked plc, which will enable it to provide its expanding product range of personalised healthcare products to a much larger number of customers."
06/2/2021
20:25
varies: It is a long time since I looked at MERC's purchase of NVM and I see that this took place in Dec. 2019. MERC paid £12.4m in cash and issued the vendors with 16.8m shares with a value of £4.2m using the placing price of 25p. It also promised deferred consideration of £6.3, payable in equal instalments on the 1st, 2nd and 3rd anniversaries of the purchase. I think that MERC has the option to make these payments in shares. The deferred consideration is conditional on most of the NVM funds transferring to and remaining under MERC management. The price of MERC shares before the announcement was 32p. MERC raised £30m to pay for this purchase at 25p but did not allow its own small shareholders to participate in the placing. This upset many of us and scored a boycott from Simon Thompson still in force today. Whilst sympathising with this reaction I believe that the course of action followed by MERC was in the long term interest of its shareholders in that NVM was well worth the price paid and such an opportunity had to be seized .
02/12/2020
07:34
redartbmud: Mercia Asset Management PLC ("Mercia", the "Group" or the "Company") Performance fee entitlement Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£872million of assets under management, is pleased to note that Northern Venture Trust PLC ("NVT") has released its preliminary results for the year ended 30 September 2020. As a consequence of NVT's strong recovery in its net asset value per share, arising in part from a very recent successful sale of one of its investments, Mercia, as investment adviser to NVT, is now entitled to receive a performance fee of £284,000. This revenue will be included in Mercia's full year consolidated financial statements for the year ending 31 March 2021. Mark Payton, Chief Executive Officer of Mercia, commented: "It is very encouraging to see the recovery in net asset value per share of Northern Venture Trust PLC, as well as similar recoveries in net asset value per share for both Northern 2 VCT PLC and Northern 3 VCT PLC. This recovery in asset prices is consistent with what we are seeing in our own direct investment portfolio." Gobsmacked from Goole. Makes a change from them giving it away.
09/7/2020
07:11
redartbmud: Mercia Asset Management PLC ("Mercia" the "Company" or the "Group") Sale of The Native Antigen Company Mercia Asset Management PLC (AIM:MERC), the proactive, regionally focused specialist asset manager, is pleased to announce the profitable sale of The Native Antigen Company Limited ("NAC") to LGC, a global leader in the life sciences tools sector, for a total cash consideration of up to £18.0million. Mercia held a 29.4% fully diluted direct holding in NAC at the date of sale and will receive initial cash proceeds of £4.8million, with up to a further £0.4million receivable upon finalisation of customary closing working capital calculations. Based upon the total anticipated amount receivable of £5.2million, the total realised return above the £2.7million holding value as at 30 September 2019, will be a further £2.5million. Of this, £0.6million will be included as a fair value increase in the Group's results for the year end ended 31 March 2020, which will be announced on 14 July 2020. The remaining balance of £1.9million will be recognised as a realised gain in the Group's interim results for the six months to 30 September 2020. The sale is anticipated to generate an 8.4x return on its original direct investment cost and a 65% internal rate of return ("IRR"). Mercia first invested in NAC in 2011 through its third-party managed funds (which as at 31 March 2020 held an additional combined 20.9% stake) and subsequently, from its own balance sheet as a direct investment in December 2014. In addition to the direct investment returns, the sale will generate a 12.1x return on a blended third-party managed funds investment cost and a 31% funds IRR. Mercia has proactively supported NAC since its first day of trading, including representation from Mercia's Chief Operating Officer Peter Dines, as a non-executive director on the NAC board through to exit. Founded in 2010, as a divestiture from a University of Birmingham spinout company, NAC has become one of the world's leading suppliers of infectious disease reagents and is widely acknowledged to be a primary source of reagents for the study of emerging diseases. Dr Mark Payton, Mercia Asset Management, CEO, said: "Keeping to our commitment of realising balance sheet investments within a three to seven year period from initial investment, NAC is the fourth full cash exit from our direct investment portfolio. It has been an excellent investment for Mercia and this sale is a strong demonstration of the value which our differentiated model can create; for investors in our managed funds, shareholders in Mercia and the founders we back. NAC is an example of an innovative regional business sourced through Mercia's network, supported initially by our managed fund capital and then scaled using our own balance sheet capital. "Mercia plays a critical role in helping the UK's most exciting regional businesses scale and I am proud of the part we have played in NAC's journey, not just as the major capital provider but also as a critical partner in helping the business achieve its potential. I look forward to watching as they continue to go from strength to strength with their new owner." Yet another transformational sale by Merc - Not. Underwhelmed from Uttoxeter.
ADVFN Advertorial
Your Recent History
LSE
MERC
Mercia Ass..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211027 14:34:27